Assessing options for poppers policy in Canada: A call to action for evidence-based policy reform
Schwartz C, Card K, Elliott R, Hollett K, Jollimore J, Pasic A, Smiley S, Tooley L, Pruden H, Knight R., Int J Drug Policy. 2023
Interest in using buprenorphine-naloxone among a prospective cohort of street-involved young people in Vancouver, Canada
Pilarinos A, Bingham B, Kwa Y, Joe R, Grant C, Fast D, Buxton JA, DeBeck K., J Subst Use Addict Treat. 2023
Recommendations for Reducing the Risk of Cannabis Use-Related Adverse Psychosis Outcomes: A Public Mental Health-Oriented Evidence Review
Fischer B., Hall W., Fidalgo T.M., Hoch E., Le Foll B., Medina-Mora M.E., Reimer J., Tibbo P.G., Jutras-Aswad D., Journal of Dual Diagnosis, 2023
Universal hepatitis C virus screening and treatment as part of prenatal care
Marshall AD, Martinello M, Zolopa C, Treloar C, Larney S., Gastroenterol Hepatol. 2023
An innovative inpatient protocol for alcohol withdrawal prevention in a 16-year-old adolescent: a case report
Moubayed D., Chadi N., Journal of Medical Case Reports, 2023
An innovative inpatient protocol for alcohol withdrawal prevention in a 16-year-old adolescent: a case report
Moubayed D, Chadi N., Journal of Medical Case Reports, 2023
Rating versus ranking in a Delphi survey: a randomized controlled trial
Del Grande C., Kaczorowski J., Trials, 2023
Women who use drugs: engagement in practices of harm reduction care
Austin T, Lavalley J, Parusel S, Collins AB, Olding M, Boyd J., Harm Reduct J. 2023
Recommendations for reducing the risk of cannabis use-related adverse psychosis outcomes: a public mental health-oriented evidence review
Fischer B, Hall W, Fidalgo TM, Hoch E, Le Foll B, Medina-Mora ME, Reimer J, Tibbo PG, Jutras-Aswad D. , Journal of Dual Diagnosis, 2023
Universal hepatitis C virus screening and treatment as part of prenatal care
Marshall A., Martinello M., Zolopa C., Treloar C., Larney S., Lancet Gastroenterol Hepatol, 2023
